Synthesis of [11C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase.
暂无分享，去创建一个
[1] Rong Zhou,et al. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators. , 2006, Journal of medicinal chemistry.
[2] Qi-Huang Zheng,et al. Purification of carbon-11 PET radiotracers from unlabeled precursors by preparative HPLC and SPE. , 2005, Biomedical chromatography : BMC.
[3] M. Phelps,et al. Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: synthesis of 18F-Iressa and related molecular probes , 2005 .
[4] J. Kendrew,et al. Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor , 2005, Molecular Cancer Therapeutics.
[5] H. Swaisland,et al. Pharmacokinetics of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat and dog , 2004, Xenobiotica; the fate of foreign compounds in biological systems.
[6] H. Swaisland,et al. Metabolic disposition of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, in rat, dog and man , 2004, Xenobiotica; the fate of foreign compounds in biological systems.
[7] B. Mock,et al. Convenient gas phase bromination of [11C]methane and production of [11C]methyl triflate. , 1999, Nuclear medicine and biology.
[8] A. D. Roberts,et al. Snythesis of [F-18]-ZD1839 as a PET Imaging Agent for Epidermal Growth Factor Receptors , 2003 .